Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Glitazones on the Vasodilatory Effect of HDL Lipoproteins and on Phospholipase A2

NCT00953498 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT00953498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00953498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Glitazones on the Vasodilatory Effect of HDL Lipoproteins and on Phospholipase A2
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2007
Completion date
March 31, 2012
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes